» Articles » PMID: 28100571

Primary Squamous Cell Carcinoma of the Thyroid with Complete Response to Radical Radiotherapy and Concurrent Cisplatin-based Chemotherapy

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2017 Jan 20
PMID 28100571
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Chemoradiotherapy and/or surgery are both potentially radical treatments for squamous cell carcinomas. Squamous cell carcinomas are considered chemosensitive tumours compared to adenocarcinomas or anaplastic thyroid malignancies. A 76-year-old man was found to have T4bN0M0 primary squamous cell carcinoma of the thyroid with encasement of the internal carotid artery. The disease was deemed unresectable. Therefore, he was treated with radical radiotherapy with concurrent cisplatin-based chemotherapy. We discuss herein the aetiology, diagnosis and management of primary squamous cell carcinoma of the thyroid. We demonstrate success of chemoradiotherapy in an unresectable case of a rare and aggressive disease.

Citing Articles

Progress in diagnosing and treating thyroid squamous cell carcinoma under the 5th edition of WHO classification.

Ding W, Gao X, Ran X Front Endocrinol (Lausanne). 2024; 14:1273472.

PMID: 38303977 PMC: 10833225. DOI: 10.3389/fendo.2023.1273472.


Primary and metastatic squamous cell carcinoma of the thyroid gland: Two case reports.

Zhao X, Hao P, Tian J, Sun J, Chen D, Cui Z Open Life Sci. 2022; 17(1):1148-1154.

PMID: 36185404 PMC: 9483828. DOI: 10.1515/biol-2022-0475.


Primary squamous cell carcinoma of the thyroid gland successfully treated with surgical resection and adjuvant chemoradiotherapy.

Chu M, Mirza O, Bishop P, Pothula V BMJ Case Rep. 2021; 14(3).

PMID: 33649031 PMC: 7929853. DOI: 10.1136/bcr-2020-241209.


Treatment optimization and prognostic considerations for primary squamous cell carcinoma of the thyroid.

Wang W, Ouyang Q, Meng C, Jing L, Li X Gland Surg. 2020; 8(6):683-690.

PMID: 32042676 PMC: 6989903. DOI: 10.21037/gs.2019.11.07.

References
1.
Forastiere A, Goepfert H, Maor M, Pajak T, Weber R, Morrison W . Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003; 349(22):2091-8. DOI: 10.1056/NEJMoa031317. View

2.
Booya F, Sebo T, Kasperbauer J, Fatourechi V . Primary squamous cell carcinoma of the thyroid: report of ten cases. Thyroid. 2006; 16(1):89-93. DOI: 10.1089/thy.2006.16.89. View

3.
DSouza G, Kreimer A, Viscidi R, Pawlita M, Fakhry C, Koch W . Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007; 356(19):1944-56. DOI: 10.1056/NEJMoa065497. View

4.
Pignon J, Le Maitre A, Maillard E, Bourhis J . Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009; 92(1):4-14. DOI: 10.1016/j.radonc.2009.04.014. View

5.
Wolf G, Fisher S, Hong W, Hillman R, Spaulding M, Laramore G . Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991; 324(24):1685-90. DOI: 10.1056/NEJM199106133242402. View